Literature DB >> 7539337

Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis.

M J Gardner1, L M Jones, J B Catterall, G A Turner.   

Abstract

A major route for the spread of ovarian cancer is by the attachment of tumour cells to the mesothelium lining in the peritoneal cavity. The expression of various adhesion molecules has been measured on freshly-prepared mesothelial cells, two mesothelial cells lines and 13 established ovarian tumour cell lines. The integrins beta 1 and beta 3, ICAM-1, and CD44 were detected on all mesothelial preparations and on many or all of the tumour lines. VCAM-I was expressed exclusively on the mesothelial cells and Lewis x was expressed on half of the tumour lines. There was low or no expression of sialyl Le(x), sialyl Le(a), integrins alpha 4, beta 1, beta 4, or E and P selectins. Only CD44 expression was significantly affected by trypsin treatment. From the known interactions of adhesion molecules, the results suggest that CD44, and beta 1 and beta 3 integrins may be important in tumour/mesothelial interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539337     DOI: 10.1016/0304-3835(95)03743-g

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  38 in total

1.  A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer.

Authors:  Katherine M Bell-McGuinn; Carolyn M Matthews; Steffan N Ho; Minal Barve; Lucy Gilbert; Richard T Penson; Ernst Lengyel; Rameshraja Palaparthy; Kye Gilder; Artemios Vassos; William McAuliffe; Sara Weymer; Jeremy Barton; Russell J Schilder
Journal:  Gynecol Oncol       Date:  2011-01-26       Impact factor: 5.482

2.  Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

Authors:  Lian-Cheng Zhu; Jian Gao; Zhen-Hua Hu; Carlton L Schwab; Hui-Yu Zhuang; Ming-Zi Tan; Li-Mei Yan; Juan-Juan Liu; Dan-Ye Zhang; Bei Lin
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.

Authors:  Jian Gao; Zhenhua Hu; Juanjuan Liu; Dawo Liu; Yanyan Wang; Mingbo Cai; Danye Zhang; Mingzi Tan; Bei Lin
Journal:  Med Oncol       Date:  2014-04-02       Impact factor: 3.064

4.  Binding of ovarian cancer cells to immobilized hyaluronic acid.

Authors:  J B Catterall; M J Gardner; L M Jones; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

Review 5.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

6.  Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.

Authors:  M J Gardner; J B Catterall; L M Jones; G A Turner
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

7.  CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins.

Authors:  R C Casey; A P Skubitz
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  The CD44 receptor is a molecular predictor of survival in ovarian cancer.

Authors:  L Rodríguez-Rodríguez; I Sancho-Torres; C Mesonero; D G Gibbon; W J Shih; G Zotalis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

9.  Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth.

Authors:  Scott A Gerber; Viktoriya Y Rybalko; Chad E Bigelow; Amit A Lugade; Thomas H Foster; John G Frelinger; Edith M Lord
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion.

Authors:  L M Jones; M J Gardner; J B Catterall; G A Turner
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.